遺伝子パネル市場：技術、製品、用途、エンドユーザー別-2025-2030年の世界予測

遺伝子パネル市場は、2023年に31億1,000万米ドルと評価され、2024年には34億1,000万米ドルに達すると予測され、CAGR 9.99％で成長し、2030年には60億6,000万米ドルに達すると予測されています。

遺伝子パネルは、次世代シーケンサー技術を用いて同時に検査される遺伝子のコレクションです。様々な疾患と関連する遺伝子変異を特定し、正確で個別化された医療を可能にするために極めて重要です。遺伝子パネルの必要性は、迅速かつ包括的な遺伝学的洞察を提供し、診断精度と治療の個別化を向上させる能力から生じる。その用途は、標的治療のための変異検出を促進する腫瘍学や、早期診断のための遺伝性疾患など、複数の領域に及ぶ。最終用途のシナリオでは、遺伝子パネルは臨床診断、研究機関、病院、特に腫瘍学と希少疾患分野で不可欠です。

市場の成長は、個別化医療に対する需要の高まり、シーケンス技術の進歩、研究資金の増加の影響を受けています。遺伝性疾患やがんの罹患率の増加は、遺伝子パネルのような効果的な診断ツールに対する需要を増大させています。最新のビジネスチャンスは、より広範な遺伝子を検出し、精度とスピードを向上させるパネルの開発にあります。個人のゲノミクスに対する意識が高まるにつれ、消費者直接遺伝子検査への関心が急増しています。企業への提言としては、より多くの希少疾患を網羅する遺伝子パネルの範囲拡大への投資や、通常の診療に検査を組み込むためのヘルスケアプロバイダーとの協力などがあります。

しかし、検査費用の高騰、複雑なデータ解釈、規制状況などの課題が市場成長の妨げとなっています。遺伝子データの複雑な性質には熟練した人材が必要であり、地域間の規制基準のばらつきは世界の市場拡大を阻害する可能性があります。事業成長のための革新的な分野としては、費用対効果の高い包括的パネルの開発や、解釈プロセスを合理化するためのデータ解析への人工知能の採用が挙げられます。企業は、疾患の原因となる変異だけでなく、より良い薬物反応のための薬理ゲノミクスもターゲットとするパネルの作成に注力することができ、個別化医療の動向を強化することができます。さらに、バイオテクノロジー企業や学術研究機関とのパートナーシップを拡大することで、進歩や市場拡大を効果的に推進することができます。また、規制の変更に積極的に対応し、それを先取りすることで、競争力を高めることもできます。

市場力学：急速に進化する遺伝子パネル市場の主要市場インサイトを公開

遺伝子パネル市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的決定の精緻化、そして新たなビジネスチャンスの獲得に備えることができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • 遺伝性疾患および希少疾患の急増
  • 個別化医薬品に対するニーズの高まり
  • がん診療におけるマルチ遺伝子パネル検査の急速な普及
• 市場抑制要因
  • 遺伝子データのセキュリティ確保の問題
• 市場機会
  • 集団シーケンシングに対する政府の積極的な取り組み
  • 臨床研究用の次世代シーケンスに基づく新しい遺伝子パネルのイントロダクション
• 市場の課題
  • 診断検査における精度への懸念と標準化の問題

ポーターのファイブフォース：遺伝子パネル市場をナビゲートする戦略ツール

ポーターのファイブフォース」フレームワークは、市場情勢の競合情勢を把握するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：遺伝子パネル市場における外部からの影響の把握

外部マクロ環境要因は、遺伝子パネル市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析遺伝子パネル市場における競合情勢の把握

遺伝子パネル市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックス遺伝子パネル市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、遺伝子パネル市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によりベンダーを明確かつ的確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨遺伝子パネル市場における成功への道筋を描く

遺伝子パネル市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大の可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • 遺伝性疾患と希少疾患の急増
    • パーソナライズされた医薬品へのニーズの高まり
    • 腫瘍学診療におけるマルチ遺伝子パネル検査の急速な導入
  • 抑制要因
    • 遺伝子データのセキュリティ確保に関する問題
  • 機会
    • 集団シーケンシングに対する政府の好ましい取り組み
    • 臨床調査のための次世代シークエンシングに基づく新しい遺伝子パネルのイントロダクション
  • 課題
    • 診断検査における精度の懸念と標準化の問題
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 遺伝子パネル市場：技術別

• マイクロアレイ
• 次世代シーケンシング
• ポリメラーゼ連鎖反応

第7章 遺伝子パネル市場：製品別

• 検査キット
• テストサービス

第8章 遺伝子パネル市場：用途別

• がん診断
• 遺伝性疾患
• 感染症
• 薬理ゲノム学

第9章 遺伝子パネル市場：エンドユーザー別

• 学術調査機関
• 病院および診断検査室
• 製薬・バイオテクノロジー企業

第10章 南北アメリカの遺伝子パネル市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域の遺伝子パネル市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカの遺伝子パネル市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• Agilent Technologies, Inc.
• Arizona Oncology
• ARUP Laboratories
• Becton, Dickinson, and Company
• BGI Group
• Bio-Rad Laboratories, Inc.
• Blueprint Genetics Oy by Quest Diagnostics
• CENTOGENE N.V.
• Cepheid by Danaher Corporation
• Eurofins Genomics LLC
• Everything Genetic Ltd.
• Fulgent Genetics
• Genewiz by Azenta Life Sciences
• Guardant Health, Inc.
• Illumina Inc.
• myGenomics
• Myriad Genetic Laboratories Inc.
• NanoString Technologies, Inc.
• Natera, Inc.
• Novogene Co, Ltd.
• PrimBio Research Institute
• Qiagen N.V.
• Thermo Fisher Scientific Inc.
• Twist Bioscience

LIST OF FIGURES

• FIGURE 1. GENE PANEL MARKET RESEARCH PROCESS
• FIGURE 2. GENE PANEL MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENE PANEL MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENE PANEL MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENE PANEL MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENE PANEL MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENE PANEL MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENE PANEL MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GENE PANEL MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GENE PANEL MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES GENE PANEL MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES GENE PANEL MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. GENE PANEL MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. GENE PANEL MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENE PANEL MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENE PANEL MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENE PANEL MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENE PANEL MARKET DYNAMICS
• TABLE 7. GLOBAL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENE PANEL MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENE PANEL MARKET SIZE, BY NEXT-GENERATION SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENE PANEL MARKET SIZE, BY POLYMERASE CHAIN REACTION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENE PANEL MARKET SIZE, BY TEST KITS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENE PANEL MARKET SIZE, BY TESTING SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENE PANEL MARKET SIZE, BY CANCER DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENE PANEL MARKET SIZE, BY GENETIC DISORDERS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENE PANEL MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENE PANEL MARKET SIZE, BY PHARMACOGENOMICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENE PANEL MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENE PANEL MARKET SIZE, BY HOSPITAL & DIAGNOSTIC LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENE PANEL MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. AMERICAS GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 24. AMERICAS GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 28. ARGENTINA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 29. ARGENTINA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 32. BRAZIL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 33. BRAZIL GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 36. CANADA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 37. CANADA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 38. CANADA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 39. CANADA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 40. MEXICO GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 41. MEXICO GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 44. UNITED STATES GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 45. UNITED STATES GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES GENE PANEL MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 49. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 50. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 54. AUSTRALIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 55. AUSTRALIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 58. CHINA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 59. CHINA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 60. CHINA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 61. CHINA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 62. INDIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 63. INDIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 64. INDIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 65. INDIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 66. INDONESIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 67. INDONESIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 70. JAPAN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 71. JAPAN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 74. MALAYSIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 75. MALAYSIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 78. PHILIPPINES GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 79. PHILIPPINES GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 82. SINGAPORE GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 83. SINGAPORE GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 86. SOUTH KOREA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 87. SOUTH KOREA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 90. TAIWAN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 91. TAIWAN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 94. THAILAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 95. THAILAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 98. VIETNAM GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 99. VIETNAM GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 102. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 103. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENE PANEL MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 107. DENMARK GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 108. DENMARK GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 111. EGYPT GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 112. EGYPT GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 115. FINLAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 116. FINLAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 119. FRANCE GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 120. FRANCE GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 123. GERMANY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 124. GERMANY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 127. ISRAEL GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 128. ISRAEL GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 131. ITALY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 132. ITALY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 133. ITALY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 134. ITALY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 135. NETHERLANDS GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 136. NETHERLANDS GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 139. NIGERIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 140. NIGERIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 143. NORWAY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 144. NORWAY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 147. POLAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 148. POLAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 149. POLAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 150. POLAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 151. QATAR GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 152. QATAR GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 153. QATAR GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 154. QATAR GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 155. RUSSIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 156. RUSSIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 159. SAUDI ARABIA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 160. SAUDI ARABIA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 163. SOUTH AFRICA GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 164. SOUTH AFRICA GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 167. SPAIN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 168. SPAIN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 171. SWEDEN GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 172. SWEDEN GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 175. SWITZERLAND GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 176. SWITZERLAND GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 179. TURKEY GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 180. TURKEY GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 183. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 184. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 187. UNITED KINGDOM GENE PANEL MARKET SIZE, BY TECHNIQUE, 2018-2030 (USD MILLION)
• TABLE 188. UNITED KINGDOM GENE PANEL MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM GENE PANEL MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM GENE PANEL MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 191. GENE PANEL MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 192. GENE PANEL MARKET, FPNV POSITIONING MATRIX, 2023

The Gene Panel Market was valued at USD 3.11 billion in 2023, expected to reach USD 3.41 billion in 2024, and is projected to grow at a CAGR of 9.99%, to USD 6.06 billion by 2030.

Gene panels are collections of genes examined simultaneously using next-generation sequencing technologies. They are crucial for identifying genetic mutations linked to various diseases, enabling precise and personalized medicine. The necessity of gene panels arises from their capacity to offer rapid, comprehensive genetic insights, improving diagnostic accuracy and treatment personalization. Applications span multiple domains, including oncology, where they facilitate mutation detection for targeted therapies, and genetic disorders for early diagnosis. In end-use scenarios, gene panels are vital in clinical diagnostics, research institutions, and hospitals, particularly within oncology and rare disease sectors.

Market growth is influenced by rising demand for personalized medicine, advancements in sequencing technologies, and increasing research funding. The growing incidence of genetic disorders and cancer augments demand for effective diagnostic tools like gene panels. The latest opportunities lie in developments of panels for more extensive gene detection and enhancements in accuracy and speed. There is a burgeoning interest in direct-to-consumer genetic testing as awareness of personal genomics rises. Recommendations for businesses include investing in expanding the scope of gene panels to encompass more rare diseases and collaborating with healthcare providers to integrate testing into regular practice.

However, challenges such as high costs of testing, complex data interpretation, and regulatory landscapes hamper market growth. The intricate nature of genetic data necessitates skilled personnel, and the variability in regulatory standards across regions can impede global market expansion. Innovative areas for business growth include developing cost-effective, comprehensive panels and employing artificial intelligence for data analysis to streamline interpretation processes. Companies can focus on creating panels that target not only disease-causing mutations but also pharmacogenomics for better drug responses, reinforcing the trend towards personalized medicine. Moreover, expanding partnerships with biotech firms and academic research institutions could propel advancements and market expansion effectively. Adapting to and anticipating regulatory changes proactively can also provide a competitive edge.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Gene Panel Market

The Gene Panel Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Surging prevalence of genetic disorders and rare disease
  • Growing need for the personalized medicines
  • Rapid adoption of multi-gene panel testing in oncology practice
• Market Restraints
  • Issues in ensuring the security of genetic data
• Market Opportunities
  • Favorable government initiatives for population sequencing
  • Introduction of new gene panels based on next-generation sequencing for clinical research
• Market Challenges
  • Accuracy concerns and standardization issues in diagnostic testing

Porter's Five Forces: A Strategic Tool for Navigating the Gene Panel Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Gene Panel Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Gene Panel Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Gene Panel Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Gene Panel Market

A detailed market share analysis in the Gene Panel Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Gene Panel Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Gene Panel Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Gene Panel Market

A strategic analysis of the Gene Panel Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Gene Panel Market, highlighting leading vendors and their innovative profiles. These include Agilent Technologies, Inc., Arizona Oncology, ARUP Laboratories, Becton, Dickinson, and Company, BGI Group, Bio-Rad Laboratories, Inc., Blueprint Genetics Oy by Quest Diagnostics, CENTOGENE N.V., Cepheid by Danaher Corporation, Eurofins Genomics LLC, Everything Genetic Ltd., Fulgent Genetics, Genewiz by Azenta Life Sciences, Guardant Health, Inc., Illumina Inc., myGenomics, Myriad Genetic Laboratories Inc., NanoString Technologies, Inc., Natera, Inc., Novogene Co, Ltd., PrimBio Research Institute, Qiagen N.V., Thermo Fisher Scientific Inc., and Twist Bioscience.

Market Segmentation & Coverage

This research report categorizes the Gene Panel Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Technique, market is studied across Microarray, Next-Generation Sequencing, and Polymerase Chain Reaction.
• Based on Product, market is studied across Test Kits and Testing Services.
• Based on Application, market is studied across Cancer Diagnostics, Genetic Disorders, Infectious Diseases, and Pharmacogenomics.
• Based on End-User, market is studied across Academic & Research Institutes, Hospital & Diagnostic Laboratories, and Pharmaceutical & Biotechnology Companies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Surging prevalence of genetic disorders and rare disease
    • 5.1.1.2. Growing need for the personalized medicines
    • 5.1.1.3. Rapid adoption of multi-gene panel testing in oncology practice
  • 5.1.2. Restraints
    • 5.1.2.1. Issues in ensuring the security of genetic data
  • 5.1.3. Opportunities
    • 5.1.3.1. Favorable government initiatives for population sequencing
    • 5.1.3.2. Introduction of new gene panels based on next-generation sequencing for clinical research
  • 5.1.4. Challenges
    • 5.1.4.1. Accuracy concerns and standardization issues in diagnostic testing
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Gene Panel Market, by Technique

• 6.1. Introduction
• 6.2. Microarray
• 6.3. Next-Generation Sequencing
• 6.4. Polymerase Chain Reaction

7. Gene Panel Market, by Product

• 7.1. Introduction
• 7.2. Test Kits
• 7.3. Testing Services

8. Gene Panel Market, by Application

• 8.1. Introduction
• 8.2. Cancer Diagnostics
• 8.3. Genetic Disorders
• 8.4. Infectious Diseases
• 8.5. Pharmacogenomics

9. Gene Panel Market, by End-User

• 9.1. Introduction
• 9.2. Academic & Research Institutes
• 9.3. Hospital & Diagnostic Laboratories
• 9.4. Pharmaceutical & Biotechnology Companies

10. Americas Gene Panel Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Gene Panel Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Gene Panel Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Agilent Technologies, Inc.
• 2. Arizona Oncology
• 3. ARUP Laboratories
• 4. Becton, Dickinson, and Company
• 5. BGI Group
• 6. Bio-Rad Laboratories, Inc.
• 7. Blueprint Genetics Oy by Quest Diagnostics
• 8. CENTOGENE N.V.
• 9. Cepheid by Danaher Corporation
• 10. Eurofins Genomics LLC
• 11. Everything Genetic Ltd.
• 12. Fulgent Genetics
• 13. Genewiz by Azenta Life Sciences
• 14. Guardant Health, Inc.
• 15. Illumina Inc.
• 16. myGenomics
• 17. Myriad Genetic Laboratories Inc.
• 18. NanoString Technologies, Inc.
• 19. Natera, Inc.
• 20. Novogene Co, Ltd.
• 21. PrimBio Research Institute
• 22. Qiagen N.V.
• 23. Thermo Fisher Scientific Inc.
• 24. Twist Bioscience